Skip to main content
    U

    Upstream Bio, Inc. (UPB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.10
    -0.05 (-2.33%)

    Market Cap: $117.84M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Upstream Bio, Inc. (UPB) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Upstream Bio (UPB) has a latest price of $2.10 on Nov 17, 2026. Its price fell 91.4% over the past 12 months.

    Price Chart

    From Oct 2024 to Oct 2026, its highest month-end close was $31.08 in Jan 2026 and its lowest $3.41 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart UPB with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for UPB.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 72.1%, and over 6 months it fell 73.8%.

    PeriodChange
    1 month-25.0%
    3 months-72.1%
    6 months-73.8%
    12 months-91.4%
    12 months, with dividends-91.4%
    Price change over each period. Dividends are not included unless the row says so.

    Price by Year

    YearCloseChange
    2026 through Oct 2026$3.41-87.4%
    2025$27.15+65.1%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 48.5% below its 50-day average of $4.08 and 72.4% below its 200-day average of $7.60.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$2.10
    50-day average$4.08-48.5%
    200-day average$7.60-72.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 93.6%.

    MeasureValue
    1-year beta1.83
    Largest fall, 1 year-93.6%
    Largest fall, 3 years-93.6%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About UPB

    What is UPB's 1-year price change?

    Upstream Bio's price fell 91.4% over the past 12 months. With dividends included, the 12-month total return was -91.4%.

    What is UPB's beta?

    Upstream Bio's 1-year beta against the S&P 500 is 1.83, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 93.6%.

    Is the UPB chart free?

    Yes. Advanced Charting for UPB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.